Drug serialization system: Advances and challenges
The counterfeiting of medications poses a direct threat to the health of millions of people each year. In response to this ever-growing threat, the European Union decided to intensify its efforts by adopting stricter regulatory measures that culminated in 2019 with the implementation of Directive 2011/62/EU and Delegated Regulation (EU) 2016/161.
Visit to Equatorial Guinea
Malabo, Republic of Equatorial Guinea The CEO of Mana Pharma, Katayun Manavi, travels to the Republic of Equatorial Guinea to meet with the Ministry of
MANA PHARMA: Committed to Supplying Medicines to Hospitals in Spain
Over the past few years, the Healthcare System in Spain has faced increasing challenges in ensuring a reliable supply of essential medicines. The shortage of certain drugs, a pressing issue impacting both patients and Healthcare professionals, has underscored the importance of a robust and reliable Distribution System.
MANA PHARMA’S regulatory affairs department
At MANA PHARMA, S.L., the Regulatory Affairs Department plays a pivotal role in ensuring regulatory compliance and global accessibility of medicines for human use, veterinary medicines, medical devices, cosmetics, and food supplements.
